Key statistics
On Thursday, HOOKIPA Pharma Inc (HOOK:NAQ) closed at 4.72, 15.12% above the 52 week low of 4.10 set on Oct 26, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.75 |
---|---|
High | 4.75 |
Low | 4.60 |
Bid | 4.60 |
Offer | 5.52 |
Previous close | 4.62 |
Average volume | 29.16k |
---|---|
Shares outstanding | 12.05m |
Free float | 7.59m |
P/E (TTM) | -- |
Market cap | 55.69m USD |
EPS (TTM) | -5.28 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
- HOOKIPA Pharma Announces Board of Directors Changes
- HOOKIPA Pharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights
- HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200
- HOOKIPA Pharma Announces Effective Date of 1-for-10 Reverse Stock Split
- HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV
- HOOKIPA Pharma Announces Updated Phase 2 Clinical Data at the American Society of Clinical Oncology 2024 Annual Meeting
- HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncology 2024 Annual Meeting
- HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting
- HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
- HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab
More ▼